Naringin suppresses the growth and motility of hypertrophic scar fibroblasts by inhibiting the kinase activity of Akt
- 1 September 2018
- journal article
- research article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 105, 1291-1298
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Therapeutic potential of naringin: an overviewPharmaceutical Biology, 2016
- IL10 inhibits starvation-induced autophagy in hypertrophic scar fibroblasts via cross talk between the IL10-IL10R-STAT3 and IL10-AKT-mTOR pathwaysCell Death & Disease, 2016
- Fangchinoline suppresses the growth and invasion of human glioblastoma cells by inhibiting the kinase activity of Akt and Akt-mediated signaling cascadesTumor Biology, 2015
- The Four-Herb Chinese Medicine ANBP Enhances Wound Healing and Inhibits Scar Formation via Bidirectional Regulation of Transformation Growth Factor PathwayPLOS ONE, 2014
- Naringin suppress chondrosarcoma migration through inhibition vascular adhesion molecule-1 expression by modulating miR-126International Immunopharmacology, 2014
- Naringin inhibits growth potential of human triple-negative breast cancer cells by targeting β-catenin signaling pathwayToxicology Letters, 2013
- Naringin Enhances CaMKII Activity and Improves Long-Term Memory in a Mouse Model of Alzheimer’s DiseaseInternational Journal of Molecular Sciences, 2013
- Naringin induces death receptor and mitochondria-mediated apoptosis in human cervical cancer (SiHa) cellsFood and Chemical Toxicology, 2013
- Akt‐mediated mechanotransduction in murine fibroblasts during hypertrophic scar formationWound Repair and Regeneration, 2010
- A High Throughput Luminescent Assay for Glycogen Synthase Kinase-3 β InhibitorsASSAY and Drug Development Technologies, 2007